Skip to main content

Singular Genomics Systems, Inc.

OMICDelisted Feb 21, 2025
Industry
Laboratory Analytical Instruments
SEC CIK
0001850906

Singular Genomics Systems, Inc. was delisted on Feb 21, 2025; its insiders filed their last Form 4 on Feb 27, 2025; 20 institutions reported holding it in 13F filings for Q4 2024, worth $21.5M in total; no superinvestor held it.

13F holders, Q2 2024

Institutional positions in Singular Genomics Systems, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
24
−18 vs. Q1 2024
Shares held
709.8K
−136.3K (−16.1%) vs. Q1 2024Converted for a 1-for-30 split
Total value
$6.00M
−$7.05M (−54.0%) vs. Q1 2024
New holders
2
5 more added
Sold out
20
6 more reduced

Compare with Q1 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting OMIC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2024: 24 institutions
Q1 2021: 0 institutionsQ2 2021: 52 institutionsQ3 2021: 52 institutionsQ4 2021: 62 institutionsQ1 2022: 69 institutionsQ2 2022: 76 institutionsQ3 2022: 74 institutionsQ4 2022: 81 institutionsQ1 2023: 66 institutionsQ2 2023: 62 institutionsQ3 2023: 48 institutionsQ4 2023: 47 institutionsQ1 2024: 42 institutionsQ2 2024: 24 institutionsQ3 2024: 22 institutionsQ4 2024: 20 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 1 institutionQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ2 2024: $6.00M
Q1 2021: $0Q2 2021: $757.4MQ3 2021: $312.4MQ4 2021: $450.2MQ1 2022: $258.7MQ2 2022: $149.1MQ3 2022: $100.5MQ4 2022: $74.8MQ1 2023: $43.4MQ2 2023: $27.3MQ3 2023: $10.6MQ4 2023: $12.1MQ1 2024: $13.1MQ2 2024: $6.00MQ3 2024: $18.4MQ4 2024: $21.5MQ1 2025: $0Q2 2025: $0Q3 2025: $512.7KQ4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding OMIC and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20251$512.7K
Q2 20250$0
Q1 20250$0
Q4 202420$21.5M
Q3 202422$18.4M
Q2 202424$6.00M
Q1 202442$13.1M
Q4 202347$12.1M
Q3 202348$10.6M
Q2 202362$27.3M
Q1 202366$43.4M
Q4 202281$74.8M
Q3 202274$100.5M
Q2 202276$149.1M
Q1 202269$258.7M
Q4 202162$450.2M
Q3 202152$312.4M
Q2 202152$757.4M
Q1 20210$0

Institutions, Q2 2024

Shares, value and share of portfolio for each institution holding Singular Genomics Systems, Inc.; share changes are against Q1 2024.

Institutions holding OMIC in Q2 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Deerfield Management Company, L.P. (Series C)166,162$1.40M0.02%00.0%UnchangedConverted for a 1-for-30 split
ARCH Venture Management, LLC126,630$1.07M0.40%00.0%UnchangedConverted for a 1-for-30 split
QVIDTVM Management LLC83,558$706.1K0.56%00.0%UnchangedConverted for a 1-for-30 split
Perceptive Advisors LLC70,896$599.1K0.01%00.0%UnchangedConverted for a 1-for-30 split
FMR LLC70,653$597.0K0.00%00.0%UnchangedConverted for a 1-for-30 split
Vanguard Group Inc62,417$527.4K0.00%00.0%UnchangedConverted for a 1-for-30 split
Casdin Capital, LLC44,129$372.9K0.03%00.0%UnchangedConverted for a 1-for-30 split
BlackRock Inc.20,437$172.7K0.00%−4,187−17.0%ReducedConverted for a 1-for-30 split
OrbiMed Advisors LLC18,023$152.3K0.00%00.0%UnchangedConverted for a 1-for-30 split
HighTower Advisors, LLC17,607$150.0K0.00%00.0%UnchangedConverted for a 1-for-30 split
Geode Capital Management, LLC16,769$141.7K0.00%+1,414+9.2%AddedConverted for a 1-for-30 split
Tikvah Management LLC10,561$89.2K0.03%00.0%UnchangedConverted for a 1-for-30 split
Tower Research Capital LLC (TRC)528$4.46K0.00%+330+166.0%AddedConverted for a 1-for-30 split
Barclays PLC409$3.46K0.00%00.0%UnchangedConverted for a 1-for-30 split
Bank of America Corp367$3.10K0.00%+11+3.2%AddedConverted for a 1-for-30 split
Morgan Stanley363$3.07K0.00%+73+25.0%AddedConverted for a 1-for-30 split
Royal Bank of Canada87$1.00K0.00%+20+30.5%AddedConverted for a 1-for-30 split
Rhumbline Advisers55$4640.00%−0−0.7%ReducedConverted for a 1-for-30 split
BNP Paribas Arbitrage, SA36$3040.00%+36New
Qube Research & Technologies Ltd22$1860.00%−1−3.2%ReducedConverted for a 1-for-30 split
JPMorgan Chase & Co20$1690.00%−1,274−98.5%ReducedConverted for a 1-for-30 split
Harbour Investments, Inc.5$420.00%−1−12.8%ReducedConverted for a 1-for-30 split
Dynamic Wealth Strategies, LLC56$00.00%−1−1.2%ReducedConverted for a 1-for-30 split
Capital Advisors, Ltd. LLC33$00.00%+33New
UBS Group AG0$00.00%−73,646−100.0%Sold outConverted for a 1-for-30 split
Verition Fund Management LLC0$00.00%−16,667−100.0%Sold outConverted for a 1-for-30 split
Hongkou Capital LP0$00.00%−6,491−100.0%Sold outConverted for a 1-for-30 split
Millennium Management LLC0$00.00%−5,867−100.0%Sold outConverted for a 1-for-30 split
Bridgeway Capital Management, LLC0$00.00%−4,050−100.0%Sold outConverted for a 1-for-30 split
Citadel Advisors LLC0$00.00%−3,897−100.0%Sold outConverted for a 1-for-30 split
State Street Corp0$00.00%−3,754−100.0%Sold outConverted for a 1-for-30 split
Renaissance Technologies LLC0$00.00%−3,707−100.0%Sold outConverted for a 1-for-30 split
Squarepoint Ops LLC0$00.00%−3,395−100.0%Sold outConverted for a 1-for-30 split
Northern Trust Corp0$00.00%−2,679−100.0%Sold outConverted for a 1-for-30 split
Weil Company, Inc.0$00.00%−2,273−100.0%Sold outConverted for a 1-for-30 split
Susquehanna International Group, LLP0$00.00%−1,704−100.0%Sold outConverted for a 1-for-30 split
Marino, Stram & Associates LLC0$00.00%−1,333−100.0%Sold outConverted for a 1-for-30 split
DLK Investment Management, LLC0$00.00%−833−100.0%Sold outConverted for a 1-for-30 split
XTX Topco Ltd0$00.00%−819−100.0%Sold outConverted for a 1-for-30 split
Goldman Sachs Group Inc0$00.00%−719−100.0%Sold outConverted for a 1-for-30 split
Engineers Gate Manager LP0$00.00%−501−100.0%Sold outConverted for a 1-for-30 split
Palumbo Wealth Management LLC0$00.00%−418−100.0%Sold outConverted for a 1-for-30 split
Wells Fargo & Company0$00.00%−13−100.0%Sold outConverted for a 1-for-30 split
Citigroup Inc0$00.00%−1−100.0%Sold outConverted for a 1-for-30 split